VPAC1 potent facilitator of HIV-1 infection

Author：

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1330, 2002-01, pp. : 10-10

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Darunavir: In the Treatment of HIV-1 Infection

By Fenton Caroline Perry Caroline M.

Drugs, Vol. 67, Iss. 18, 2007-01 ,pp. : 2791-2801

Adis International

Access to resources Recommend Favorite

Antiretroviral therapies in HIV-1 infection

By Morris-Jones S. Moyle G. Easterbrook P.J.

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 8, 1997-08 ,pp. : 1049-1062

Informa Healthcare

Access to resources Recommend Favorite

Starting treatment of HIV-1 infection with a simple, but potent, antiretroviral regimen produces comparable virological results as those seen when starting therapy with more drugs

Inpharma, Vol. 1, Iss. 1235, 2000-01 ,pp. : 15-15

Adis International

Access to resources Recommend Favorite

Short and unexpectedly potent 3-pyrrolidinone type inhibitors of HIV-1 replication

By Bouygues M. Medou M. Chermann J.-C. Camplo M. Kraus J.-L.

European Journal of Medicinal Chemistry, Vol. 33, Iss. 6, 1998-06 ,pp. : 445-450

Elsevier

Access to resources Recommend Favorite

Etravirine: potent antiviral activity in HIV-1 with NNRTI resistance

Inpharma, Vol. 1, Iss. 1423, 2004-01 ,pp. : 9-9

Adis International

Access to resources Recommend Favorite